Author

Michael Selgrad 1

1 Department Of Gastroenterolgy, Hepatology , Otto-Von-Guericke University, Magdeburg, Germany

A NEW, BIOLOGICALLY RELEVANT CLASSIFICATION FOR ADENOCARCINOMA AT THE GASTRO-OESOPHAGEAL JUNCTION.

Jan Bornschein, Juliane Perner, Lorenz Wernisch, Maria Secrier, Shona Macrae, Ahmad Miremadi, Maria O'Donovan, Michael Selgrad, Marino Venerito, Lawrence Bower, Matthew Eldridge, Peter Malfertheiner, Rebecca Clare Fitzgerald

DIFFERENT ANTIBIOTIC SUSCEPTIBILITY BETWEEN ANTRUM AND CORPUS OF THE STOMACH, A POSSIBLE REASON FOR TREATMENT FAILURE OF HELICOBACTER PYLORI INFECTION

Michael Selgrad, Ina Tammer, Jan Bornschein, Julia Meissle, Arne Kandulski, Dirk Schlüter, Peter Malfertheiner

DKK-2, A MODULATOR OF WNT-SIGNALING PATHWAY, IS OVEREXPRESSED IN GASTRIC CANCER

Michael Selgrad, Jan Bornschein, Michael Vieth, Peter Malfertheiner

GENE-EXPRESSION OF THE WNT-MODULATOR RACGAP1 CORRELATES INVERSELY WITH CDKN1A (P21) IN PATIENTS WITH GASTRIC CANCER.

Jan Bornschein, Jessica Nielitz, Michael Selgrad, Kinga Toth, Doerthe Kuester, Alexander Link, Peter Malfertheiner

HELICOBACTER PYLORI, DECREASED PEPSINOGEN AND ATROPHIC GASTRITIS ARE NOT ASSOCIATED WITH BARRETTS ESOPHAGUS AND EROSIVE ESOPHAGITIS

Michael Selgrad, Arne Kandulski, Albert Roessner, Jan Bornschein, Peter Malfertheiner

Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

Peter Malfertheiner, Francis Megraud, Colm O Morain, Javier Gisbert, Ernst J. Kuipers, A Axon, Franco Bazzoli, Antonio Gasbarrini, John Atherton, David Y. Graham, Richard Hunt, Paul Moayyedi, Theodore Rokkas, Massimo Rugge, Michael Selgrad, S. Suerbaum, Kokichi Sugano, Emad El-Omar

S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease

Wolfgang Fischbach, Peter Malfertheiner, P. Lynen Jansen, W. Bolten, Jan Bornschein, Stephan Buderus, E. Glocker, J.C. Hoffmann, Sibylle Koletzko, Joachim Labenz, Julia Mayerle, Stephan Miehlke, Joachim Mössner, U. Peitz, C. Prinz, Michael Selgrad, S. Suerbaum, Marino Venerito, Michael Vieth

SAFETY OF DAA THERAPY REGARDING RENAL FUNCTION IN POST-LIVER TRANSPLANT PATIENTS INFECTED WITH HEPATITIS C INDEPENDENT OF PRE-EXISTING RENAL IMPAIRMENT, AND A 100% SVR12 RATE - A SINGLE CENTRE STUDY

Georg Peschel, Lucia Baier, Lukas Moleda, Michael Selgrad, Marcus Scherer, Martina Müller, Kilian Weigand

Item 1 - 8 / 23
1
2 3